Hemadrol, 30 Caps (EST)
Product Info ► Label Info ► Reviews/Results ► Articles
EST Hemadrol [Product Information]: |
Hemadrol is categorized as a unique "Pro Anabolic". As this compound is legal, it may be the strongest, most effective compound to date (That's still legal anyway!).
Hemadrol increases testosterone baseline blood levels, while inducing muscle hypertrophy and promoting astonishing strength gains; and can not aromatize as the structure will not allow it. While yielding these amazing strength and muscle gains, Hemadrol also promotes body fat reduction and aerobic energy.
Hemadrol is so effective that users have reported gains within 2 days of use. This is due to the fact of Hemadrol's amazing ability to enter the body's bloodstream so quickly and efficiently.
Hemadrol Highlights:
- Promote and increase in free testosterone baseline blood levels
- Promote Muscle Hypertrophy
- Promote Strength Gains
|
EST Hemadrol [Supplement Facts]: |
Serving Size: 1 Capsule
Servings Per Container: 30
Amount Per Serving:
4-chloro-17a-methyl-androst-1,4-diene-3-17b-diol: 50mg
Hemadrol Directions: As a dietary supplement, take one (1) capsule per day. Donot exceed recommended dose.
Warnings: Do not use Hemadrol if you are at risk or are being treated for high blood pressure, heart, kidney, thyroid or psychiatric disease, anxiety, depression, seizure disorders or stroke. Not for use in women or in any persons under the age of 21. Use only for a period of 30 days. Wait 90 days prior to using the product again.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
|
Buy EST Hemadrol today!
Save more on EST Hemadrol with our instant coupons and quantity discounts! |
Average rating of reviews is 5 2007-12-19 By: SCOOP Cape Coral,Florida This stuff works great. Instant gains in strength and size,3 months later I have kept all I gained. I am ordering more right after I finish typing.
|  | ► Related / You May Also Like: | | | | | | | |
|
|
